Combined treatments with Ninjin-youei-to (Ren-shen-yang-rong-tang) plus a suboptimal dose of prednisolone on autoimmune nephritis in MRL/lpr mice

International Journal of Immunopharmacology

Volumn 20, Issue 6, 1998, Pages 275-284

  Nakai, Shoji ^a   Kawakita, Takuya ^a   Himeno, Kunisuke ^b   Nomoto, Kikuo ^c  

^a KANEBO LTD   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

MRL lpr mice; Nephritis; Ninjin youei to; Prednisolone

Indexed keywords

AUTOANTIBODY; HERBACEOUS AGENT; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CHINESE HERB; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; SPICE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIGEN-ANTIBODY COMPLEX; AUTOIMMUNE DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; FEMALE; KIDNEY; MICE; MICE, INBRED C3H; MICE, INBRED MRL LPR; NEPHRITIS; PREDNISOLONE; PROTEINURIA; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031856606     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(98)00032-0     Document Type: Article

References (35)

1. Andrews, B.S., Eisenberg, R.A., Theofilopoulos, A.N., Izui, S., Wilson, C.B., McConahey, P.J., Murphy, E.D., Roths, J.B., Dixon, F.J., 1978. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J. Exp. Med., 148, 1198-1215.
2. Border, W.A., Okuda, S., Languino, L.R., Sporn, M.B., Ruoslahti, E., 1990. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 346, 371-374.
3. Dauphin, M.S., Kipper, S.B., Wofsy, C., Talal, N., 1981. Interleukin 2 deficiency is a common feature of autoimmune mice. J. Immun., 127, 2483-2487.
4. Fan, J.-L., Himeno, K., Tsuru, S., Nomoto, K., 1987. Treatment of autoimmune MRL/Mp-lpr/lpr mice with cholera toxin. Clin. Exp. Immun., 70, 94-101.
5. Harigai, E., Nakai, S., Kawakita, T., Nomoto, K., 1995. Combined treatment with Ren-shen-yang-rong-tang (Japanese Name: Ninjin-youei-to) plus prednisolone on adjuvant-induced arthritis. Int. J. Immunopharmacol., 17, 411-418.
6. Herron, L.R., Eisenberg, R.A., Roper, E., Nakkanaiah, V.N., Cohen, P.I., Kotzin, B.L., 1993. Selection of the T cell receptor repertoire in lpr mice. J. Immun., 151, 3450-3459.
7. Izui, S., Elder, J.H., McConahey, P.J., Dixon, F.J., 1979. Association of circulating retro viral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus. J. Exp. Med. 149, 1099-1116.
8. Izui, S., Kelley, V.E., Masuda, K., Yoshida, H., Roths, J.B., Murphy, E.D., 1984. Induction of various autoantibodies by mutant gene lpr in several strains of mice. J. Immun., 133, 227-233.
9. Jabs, D.A., Burek, C.L., Hu, Q., Cuppers, R.C., Lee, B., Prendergast, R.A., 1992. Anti-CD4 monoclonal antibody therapy suppresses autoimmunedisease in MRL/Mp-lpr/lpr mice. Cell Immun., 141, 496-507.
10. Jabs, D. A., Prendergast, R. A., 1987. Reactive lymphocytes in lacrimal gland and vasculitic renal lesions of autoimmune MRL/lpr mice express L3T4, J. Exp. Med., 166, 1198-1203.
11. Jevnikar, A.M., Grusby, M.J., Glimcher, L.H., 1994. Prevention of nephritis in major histocompatibility complex class II-deficient MRL/lpr mice. J. Exp. Med., 179, 1137-1143.
12. Kagami, S., Border, W.A., Miller, D.E., Noble, N.A., 1994. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J. Clin. Invest., 93, 2431-2437.
13. Keliey, V.E., Winkelstein, A., Izui, S., Dixon, F.J., 1981. Prostaglandin E1 inhibits T cell proliferation and renal disease in MRL/lpr mice. Clinical Immun. Immunopath., 21, 190-203.
14. Kishimoto, T., 1989. The biology of interleukin-6. Blood, 74, 1-10.
15. Koh, D.-R., Ho, A., Rahemtulla, A., Fung-Leung, W.P., Griesser, H., Mak, T.-W., 1995. Murine lupus in MRL/lpr mice lacking CD4 or CD8 T cells. Eur. J. Immun., 25, 2558-2562.
16. Mihara, M., Ohsugi, Y., 1989. Autoimmune kidney disease in MRL/Mp-lpr/lpr mice inhibited by OK-432, a streptococcal preparation. Clin. Exp. Immun., 78, 102-107.
17. Mountz, J.D., Gause, W.C., Finkelman, F.D., Steinberg, A.D., 1987. Prevention of lymphadenopathy in MRL-lpr/lpr mice by blocking peripheral lymph node homing with Mel-14 in vivo. J. Immun., 140, 2943-2949.
18. Mountz, J.D., Smith, T.M., Toth, K.S., 1990. Altered expression of self-reactive T cell receptor V β regions in autoimmune mice. J. Immun., 144, 2159-2166.
19. Mountz, J.D., Smith, H.R., Wilder, R.L., Reeves, J.P., Steinberg, A.D., 1987. CS-A therapy in MRL/lpr/lpr mice: amelioration of immunopathology despite autoantibody production. J. Immun., 138, 157-163.
20. + T cells in Ipr/lpr mice. J. Exp. Med., 172, 1805-1817.
21. + T cell population bearing a distinctive β chain in MRL lpr/lpr mice suggests a role for the fas protein in peripheral T cell selection. Eur. J. Immun., 24, 2761-2766.
22. Nakai, S., Kawakita, T., Nagasawa, H., Himeno, K., Nomoto, K., 1996. Thymus-dependent effect of a traditional Chinese medicine, Ren-shen-yang-rong-tang (Japanese name; Ninjin-youei-to), in autoimmune MRL/Mp-lpr/lpr mice. Int. J. Immunopharmac., 18, 271-279.
23. Nakai, S., Kawakita, T., Zhou, N., Matsuura, K., Oka, M., Nagasawa, H., Saito, Y., Suzuki, A., Himeno, K., Nomoto, K., 1993. Treatment effect of a traditional Chinese medicine, Ren-shen-yang-rong-tang (Japanese name: Ninjinyouei-to), on autoimmune MRL/Mp-lpr/lpr mice. Int. J. Immunopharmac., 15, 589-596.
24. Russell, J.H., Rush, B., Weaver, C., Wang, R., 1993. Mature T cells of autoimmune Ipr/lpr mice have a defect in antigen-stimulated suicide. Proc. Natn. Acad. Sci., 90, 4409-4413.
25. Strober, S., Kotzin, B., Field, E., Hoppe, R., Myers, B., Tanay, A., 1986. Treatment of autoimmune disease with total lymphoid irradiation. Ann. New York Acad. Sci., 475, 285-295.
26. Suematsu, S., Matsuda, T., Aozaka, K., Akira, S., Nakano, N., Ohno, S., Miyazaki, J., Yamamura, K., Hirano, T., Kishimoto, T., 1989. IgG1 plasmacytosis in interleukin-6 transgenic mice. Proc. Natn. Acad. Sci., 86, 7547-7551.
27. Tang, B., Matsuda, T., Akira, S., Nagata, N., Ikehara, S., Hirano, T., Kishimoto, T., 1991. Age associated increase in interleukin 6 in MRL/lpr mice. Int. immun., 3, 273-278.
28. Theofilopoulos, A.N., Dixon, F.J., 1985. Murine models of systemic lupus erythematosus. Adv. Immunol., 37, 269-390.
29. Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins, N.A., Nagata, S., 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature, 356, 314-317.
30. Weston, K.M., Ju, S.-T., Lu, C.Y., Sy, M.S., 1988. Autoreactive T cells in MRL/Mp-lpr/lpr mice, characterization of the lymphokine production and analysis of antigen-presenting cells required. J. Immun., 141, 1941-1948.
31. Wofsy, D., Murphy, E.D., Roths, J.B., Dauphinee, M.J., Kipper, S.B., Talal, N., 1981. Deficient interleukin 2 activity in MRL/Mp and C57BL/6J mice bearing the lpr gene. J. Exp. Med., 154, 1671-1680.
32. Yamamoto, K., Mori, A., Nakahama, T., Ito, M., Okudaira, H., Miyamoto, T., 1990. Experimental treatment of autoimmune MRL-lpr/lpr mice with immunosuppressive compound FK-506. Immunology, 69, 222-227.
33. Yayama, K., Makino, J., Takano, M., Okamoto, H., 1995. Role of angiotensin II in the transforming growth factor-beta 1 expression of rat kidney in antiglomerular basement membrane antiserum-induced glomerulonephritis. Biol. Pharm. Bull., 18, 687-690.
34. Zhou, N., Nakai, S., Kawakita, T., Oka, M., Nagasawa, H., Himeno, K., Nomoto, K., 1994. Combined treatment of autoimmune MRL/Mp-lpr/lpr mice with a herbal medicine, Ren-shen-yang-rong-tang (Japanese name : Ninjin-youeito) plus suboptimal dosage of prednisolone. Int. J. Immunopharmac., 16, 845-854.
35. Zhou, T., Bluethmann, H., Eldridge, J., Berry, K., Mounts, J.D., 1993. Origin of CD4-CD8-B220 + T cells in MRL-lpr/lpr mice. Clues from a T cell receptor β transgenic mouse. J. Immun., 150, 3651-3667.